Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease.
Layton JB, Ziemiecki R, Johannes CB, Pladevall-Vila M, Khan AM, Ebert N, Kovesdy CP, Christiansen CF, García-Sempere A, Kanegae H, Coleman CI, Walsh M, Andersen IT, Rodríguez-Bernal C, Cabaniñas CR, Thomsen RW, Farjat AE, Gay A, Gee P, Hurtado I, Kashihara N, Munch PV, Liu F, Okami S, Yamashita S, Yano Y, Vizcaya D, Oberprieler NG. Layton JB, et al. Among authors: ebert n. Diabetes Ther. 2025 Jun 4. doi: 10.1007/s13300-025-01750-7. Online ahead of print. Diabetes Ther. 2025. PMID: 40465145
What can we learn from an intersectionality-informed description of study participants? Results from the German National Cohort.
Jaehn P, Rach S, Bolte G, Mikolajczyk R, Merz S, Herrera-Espejel PS, Brand T, Führer A, Berger K, Teismann H, Bohn B, Koch-Gallenkamp L, Brenner H, Klett-Tammen CJ, Castell S, Ebert N, Emmel C, Schmidt B, Gastell S, Schulze MB, Obi N, Harth V, Holleczek B, Jaskulski S, Katzke V, Kaaks R, Willich SN, Keil T, Weber A, Leitzmann M, Wirkner K, Meinke-Franze C, Schipf S, Schikowski T, Schneider A, Slesinski SC, Moreno-Velásquez I, Pischon T, Holmberg C. Jaehn P, et al. Among authors: ebert n. Int J Equity Health. 2025 May 26;24(1):151. doi: 10.1186/s12939-025-02521-3. Int J Equity Health. 2025. PMID: 40420085 Free PMC article.
Discordant Results Between Creatinine- and Cystatin C-based Equations for Estimating GFR.
Delanaye P, Flamant M, Vidal-Petiot E, Björk J, Nyman U, Grubb A, Bakker SJL, de Borst MH, van Londen M, Derain-Dubourg L, Rule AD, Eriksen BO, Melsom T, Sundin PO, Ebert N, Schaeffner E, Hansson M, Littmann K, Larsson A, Stehlé T, Cavalier E, Bukabau JB, Sumaili EK, Yayo E, Mariat C, Moranne O, Christensson A, Lanot A, Pottel H. Delanaye P, et al. Among authors: ebert n. Kidney Int Rep. 2025 Jan 29;10(4):1248-1259. doi: 10.1016/j.ekir.2025.01.030. eCollection 2025 Apr. Kidney Int Rep. 2025. PMID: 40303200 Free PMC article.
Age- and sex-specific reference values of estimated glomerular filtration rate for European adults.
Astley ME, Chesnaye NC, Hallan S, Gambaro G, Ortiz A, Carrero JJ, Ebert N, Eriksen BO, Faucon AL, Ferraro PM, Indridason OS, Ittermann T, Jonsson AJ, Rise Langlo KA, Melsom T, Schaeffner E, Stracke S, Stel VS, Jager KJ. Astley ME, et al. Among authors: ebert n. Kidney Int. 2025 Jun;107(6):1076-1087. doi: 10.1016/j.kint.2025.02.025. Epub 2025 Mar 22. Kidney Int. 2025. PMID: 40122341 Free article.
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study.
Pladevall-Vila M, Ziemiecki R, Johannes CB, Khan AM, Mines D, Ebert N, Kovesdy CP, Thomsen RW, Baak BN, García-Sempere A, Kanegae H, Coleman CI, Walsh M, Andersen IT, Bernal CR, Cabaniñas CR, Christiansen CF, Farjat AE, Gay A, Gee P, Herings RMC, Hurtado I, Kashihara N, Kristensen FPB, Liu F, Okami S, Overbeek JA, Beest FJAP, Yamashita S, Yano Y, Layton JB, Vizcaya D, Oberprieler NG. Pladevall-Vila M, et al. Among authors: ebert n. Diabetes Ther. 2025 May;16(5):931-954. doi: 10.1007/s13300-025-01717-8. Epub 2025 Mar 19. Diabetes Ther. 2025. PMID: 40106222 Free PMC article.
Change in Urine Albumin-Creatinine Ratio and Occurrence of Hyperkalemia in Patients Initiating Finerenone in the USA: A Cohort Study from the FOUNTAIN Platform.
Kovesdy CP, Ebert N, Vizcaya D, Walsh M, Kosiborod MN, Layton JB, Ziemiecki R, Johannes CB, Pladevall-Vila M, Gee PO, Jefferson N, Chicoye A, Lopes M, Thapa BB, Curhan G, Rangel L, Bhartia M, Liu F, Farjat AE, Oberprieler NG. Kovesdy CP, et al. Among authors: ebert n. Nephron. 2025 Feb 27:1-13. doi: 10.1159/000543923. Online ahead of print. Nephron. 2025. PMID: 40015260 Free article.
183 results